A phase 1, single-center, placebo-controlled, double-blind study to assess the single dose pharmacokinetics of CC-8490 in healthy volunteers

被引:0
|
作者
Scheffler, M [1 ]
Wu, A [1 ]
Teo, S [1 ]
Friedman, G [1 ]
Faleck, H [1 ]
Zeldis, J [1 ]
Stirling, DI [1 ]
Thomas, SD [1 ]
机构
[1] Celgene Corp, Warren, NJ USA
来源
JOURNAL OF CLINICAL PHARMACOLOGY | 2003年 / 43卷 / 09期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
71
引用
收藏
页码:1030 / 1030
页数:1
相关论文
共 50 条
  • [11] Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies on the Safety, Tolerability, and Pharmacokinetics of Naldemedine in Healthy Volunteers
    Fukumura, Kazuya
    Yokota, Takaaki
    Baba, Yuko
    Ferreira, Juan Camilo Arjona
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (05): : 474 - 483
  • [12] Effect of single caffeine intake on neuropsychological functions in healthy volunteers: A double-blind placebo-controlled study
    Konishi, Yuki
    Hori, Hikaru
    Ide, Kenta
    Katsuki, Asuka
    Atake, Kiyokazu
    Igata, Ryohei
    Kubo, Takamitsu
    Tominaga, Hirotaka
    Beppu, Hiroki
    Asahara, Toshio
    Yoshimura, Reiji
    PLOS ONE, 2018, 13 (10):
  • [13] Double-blind, placebo-controlled phase 1 single ascending dose study of sage-718
    Murck, H.
    Paskavitz, J.
    Hoffmann, E.
    Li, S.
    Silber, C.
    Quirk, M.
    Varoglu, M.
    Webster, I.
    Sankoh, A.
    Doherty, J.
    Kanes, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S128 - S128
  • [14] Efficacy of IncobotulinumtoxinA on Maskne: Evaluation in a Prospective, Single-Center, Placebo-Controlled, Double-Blind Study
    Kerscher, Martina
    Buntrock, Heike
    Gluecklich, Stefanie
    TOXICON, 2024, 237 : 39 - 39
  • [15] Safety, tolerability, and pharmacokinetics of oral baicalein tablets in healthy Chinese subjects: A single-center, randomized, double-blind, placebo-controlled multiple-ascending-dose study
    Li, Lijun
    Gao, Hongzhi
    Lou, Kun
    Luo, Hongmei
    Hao, Sheng
    Yuan, Jing
    Liu, Zeyuan
    Dong, Ruihua
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (05): : 2017 - 2024
  • [16] A Phase 1, Single-center, Double-blind, Placebo-controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Clinical Effects, and Pharmacokinetics-Pharmacodynamics of Intravenous Cyclopropyl-methoxycarbonylmetomidate (ABP-700) after a Single Ascending Bolus Dose
    Struys, Michel M. R. F.
    Valk, Beatrijs I.
    Eleveld, Douglas J.
    Absalom, Anthony R.
    Meyer, Peter
    Meier, Sascha
    den Daas, Izaak
    Chou, Thomas
    van Amsterdam, Kai
    Campagna, Jason A.
    Sweeney, Steven P.
    ANESTHESIOLOGY, 2017, 127 (01) : 20 - 35
  • [17] A phase 1, single-center, randomized, double-blind, placebo controlled, single ascending dose study to investigate the safety, tolerability, and pharmacokinetics of intravenous and subcutaneous garadacimab (CSL312) in healthy subjects
    McKenzie, A.
    Roberts, A.
    Malandkar, S.
    Feuersenger, H.
    Panousis, C.
    Pawaskar, D.
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 562 - 563
  • [18] A Randomized, Placebo-Controlled, Double-Blind Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Repeated Doses of Mirogabalin in Healthy Asian Volunteers
    Jansen, Mendel
    Warrington, Steven
    Dishy, Victor
    Ohwada, Shoichi
    Johnson, Lisa
    Brown, Karen
    Ishizuka, Hitoshi
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (06): : 661 - 669
  • [19] A single-center, double-blind, placebo-controlled evaluation of lamotrigine in the treatment of obesity in adults
    Merideth, CH
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (02) : 258 - 262
  • [20] Duration of cortisol suppression following a single dose of dexamethasone in healthy volunteers: a randomised double-blind placebo-controlled trial
    Elston, M. S.
    Conaglen, H. M.
    Hughes, C.
    Tamatea, J. A. U.
    Meyer-Rochow, G. Y.
    Conaglen, J. V.
    ANAESTHESIA AND INTENSIVE CARE, 2013, 41 (05) : 596 - 601